Targeting Vector Enhances Homologous Recombination Efficiency
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current gene therapy methods, particularly those using viral vectors, face inefficiencies in homologous recombination (HR) frequencies and safety concerns due to random integration, leading to potential side effects and limited effectiveness in achieving targeted gene modifications in mammalian cells.
Innovation Solution
The development of targeting vectors that include a nuclear localization signal (NLS) and bait peptides, such as RAD51 binding peptides, to enhance the recruitment of HR machinery, thereby increasing the frequency of homologous recombination at specific genomic loci like the HPRT locus, reducing random integration, and improving gene targeting efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If viral vectors are used for gene therapy, then gene delivery efficiency is improved, but safety deteriorates due to random integration causing inactivation or activation of endogenous genes
Solution Approach 1:
The patent introduces a targeting vector as an intermediary carrier that mediates gene delivery through homologous recombination instead of direct viral integration. This vector includes homology arms that guide precise insertion at the desired genomic locus, eliminating the random integration problem while maintaining efficient delivery through the viral vector mechanism
Solution Approach 2:
The patent changes the integration mechanism parameter from random integration (viral) to homologous recombination (targeted). By modifying the molecular mechanism of integration through the use of homology arms and targeting sequences, the system achieves both efficient delivery and safe, predictable insertion at specific genomic locations
2Productivity
If homologous recombination frequency is increased through targeting vectors, then gene targeting efficiency is improved, but the complexity of the system increases
Solution Approach 1:
The patent segments the targeting vector into distinct functional modules: homology arms for precise targeting, selection markers for identifying successful integrants, and essential gene sequences. This modular segmentation allows each component to perform its specific function efficiently while simplifying the overall design and construction of the targeting system
Solution Approach 2:
The patent creates a universal targeting vector platform that can be applied to different genomic loci and gene therapy applications by simply changing the homology arms and insertion sequences. This multi-functional design maintains high targeting efficiency across different targets while avoiding the need to develop entirely new systems for each application, thereby reducing overall complexity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly enhances the frequency of targeted recombination events while minimizing random integration, offering a safer and more effective method for gene therapy by increasing the precision and efficiency of gene modification in mammalian cells.
Implementation Method 1
a nuclear localization signal ('NLS') sequence, which allows the entire targeting vector to enter the nucleus of a transfected cell
Implementation Method 2
a bait peptide attached to the end of the targeting vector that is distal to the end to which the NLS is attached. The bait peptide is an amino acid sequence that enables the targeting vector to bind to the homology recognition machinery (which includes the catalytic triad) of the cell. Preferred bait peptides recognize RAD51 (recA)
Implementation Method 3
The HR pathway entails pairing of homologous DNAs, strand exchange between them, and resolution of one or more Holliday junctions. A network of interacting proteins catalyzes each step. RAD51 provides the enzymatic functions for recognition of homology and DNA strand exchange in HR. RAD51 binds and polymerizes onto the introduced DNA in a step called presynapsis. In the next step, the RAD51 nucleoprotein filament searches for homologous regions in chromosomal DNA, catalyzes pairing between introduced and endogenous DNA, and promotes strand exchange
Implementation Method 4
When DNA is introduced into mammalian cells by transfection, the cell machinery integrates transfected DNA into the genome by one of two routes: (1) a HR pathway in which the introduced DNA replaces the endogenous genomic sequences
Data Source
AI summary
Disclosed are vectors, kits and methods useful in the construction of recombinant cells and DNAs via enhanced efficiency homologous recombination. The vectors are targeting vectors that contain a gene-of-interest spliced between two ends that are homologous to a genome target site. The ends of the vector may be protected from exonuclease attack by deploying a cap, such as a hair pin structure. The vector is linked to a nuclear localization signal sequence, and preferably, a bait peptide that binds to RAD51, to facilitate homologous recombination. The vector may be deployed in myriad genetic transformation applications, such as site-directed mutagenesis, gene therapy, and the like.